[HTML][HTML] Antidepressant use during acute inpatient care is associated with an increased risk of psychiatric rehospitalisation over a 12-month follow-up after discharge

MP Hengartner, S Passalacqua, A Andreae… - Frontiers in …, 2019 - frontiersin.org
Background: Some evidence suggests that antidepressants may relate to poor outcomes in
depression. The aim of this study was, therefore, to examine, whether antidepressant use …

Influence of study characteristics, methodological rigour and publication bias on efficacy of pharmacotherapy in obsessive-compulsive disorder: a systematic review …

SE Cohen, JB Zantvoord, BWC Storosum… - BMJ Ment …, 2024 - mentalhealth.bmj.com
Question We examined the effect of study characteristics, risk of bias and publication bias on
the efficacy of pharmacotherapy in randomised controlled trials (RCTs) for obsessive …

Biases in reporting of adverse effects in clinical trials, and potential impact on safety assessments in systematic reviews and therapy guidelines

T Westergren, S Narum, M Klemp - Basic & Clinical …, 2022 - Wiley Online Library
Background Clinical trials are an important source of adverse effects data, including
analyses in systematic reviews and recommendations in therapy guidelines. Trial …

[PDF][PDF] Физическая нагрузка при лечении депрессии. Физиологические механизмы

ВВ Гультяева, МИ Зинченко… - … и психиатрии им …, 2019 - researchgate.net
Резюме В обзоре литературы рассматриваются метаанализы, систематические
обзоры и оригинальные исследования за последнее десятилетие, посвященные …

Association between duration of antidepressant treatment for major depressive disorder and relapse rate after discontinuation: A meta-analysis

Y Hu, H Xue, X Ni, Z Guo, L Fan, W Du - Psychiatry Research, 2024 - Elsevier
The optimal duration of antidepressant treatment for patients with major depressive disorder
to reduce the risk of relapse after discontinuation remains uncertain. Medline, Cochrane …

[HTML][HTML] Short-and long-term antidepressant clinical trials for major depressive disorder in youth: findings and concerns

DJ Safer, JM Zito - Frontiers in Psychiatry, 2019 - frontiersin.org
The diagnosis of major depressive disorder (MDD) in US youth is increasing as is the rate of
antidepressant medication (ADM) treatment for the disorder. Fluoxetine and escitalopram …

[HTML][HTML] Guidelines for the pharmacological acute treatment of major depression: conflicts with current evidence as demonstrated with the German S3-guidelines

M Plöderl, MP Hengartner - BMC psychiatry, 2019 - Springer
Several international guidelines for the acute treatment of moderate to severe unipolar
depression recommend a first-line treatment with antidepressants (AD). This is based on the …

[HTML][HTML] Revisitando Whitaker: psicofármacos e cuidado em Saúde Mental na Atenção Primária à Saúde

AC Secco, CD Tesser - Saúde em Debate, 2023 - SciELO Public Health
RESUMO Os Problemas de Saúde Mental (SM) e o uso indiscriminado de psicofármacos
são problemas de grande relevância para a Atenção Primária à Saúde (APS) e a saúde …

Effektivität von Antidepressiva bei der vollstationären Psychotherapie von Depression: eine naturalistische kontrollierte Studie

R Maß, K Backhaus, M Szelies, BK Unkelbach - Verhaltenstherapie, 2023 - karger.com
Zusammenfassung Hintergrund: Zahlreiche Doppelblindstudien (randomized controlled
trials, RCTs) und Metaanalysen verweisen auf die Wirksamkeit von Antidepressiva (AD) …

[HTML][HTML] Revisiting Whitaker: psychotropic drugs and Mental Health care in Primary Health Care

AC Secco, CD Tesser - Saúde em Debate, 2023 - SciELO Public Health
Mental Health (MH) issues and the indiscriminate use of psychotropic drugs are a great deal
of a problem for the Primary Health Care (PHC) and public health. The aim of this article is to …